Endpoint Clinical is a global leader in randomization and trial supply management (RTSM) solutions for clinical trials, established in 2009. Headquartered in Raleigh-Durham, North Carolina, the company operates additional offices in the United States, Europe, and Asia. With a workforce of approximately 600 to 650 employees, Endpoint Clinical has supported over 2,000 clinical studies across more than 90 countries, managing over 650,000 patients and 90,000 sites.

The company offers advanced RTSM platforms, including their proprietary PULSE system, which enhances supply chain efficiency and ensures accurate patient dosing. Their services also include Interactive Response Technology (IRT) for trial randomization and supply management, as well as electronic Patient-Reported Outcomes (ePRO) solutions for capturing patient data. Endpoint Clinical focuses on delivering quality and innovation, integrating technology with dedicated support to adapt to trial changes and mitigate risks. They serve pharmaceutical companies, clinical trial sponsors, and life sciences organizations, positioning themselves as a trusted partner in clinical research.